Key Quantitative Figures - Standalone (FY2026)

  • Revenue from Operations: ₹63,568.85 lakhs
  • Other Income: ₹4,595.52 lakhs
  • Total Income: ₹68,284.37 lakhs
  • Net Profit/(Loss) after tax & Exceptional Items: ₹2,556.82 lakhs (Profit)
  • Total Comprehensive Income: ₹1,682.32 lakhs
  • Paid-up Equity Share Capital: ₹8,683.65 lakhs
  • Reserves excluding revaluation reserves: ₹1,37,069.72 lakhs
  • Basic EPS: ₹5.09
  • Diluted EPS: ₹4.97

Key Quantitative Figures - Standalone (Q4 FY2026)

  • Revenue from Operations: ₹17,270.06 lakhs
  • Other Income: ₹210.50 lakhs
  • Total Income: ₹17,911.11 lakhs
  • Net Profit/(Loss) after tax & Exceptional Items: ₹1,493.86 lakhs (Profit)
  • Total Comprehensive Income: ₹1,406.47 lakhs

Key Quantitative Figures - Consolidated (FY2026)

  • Net Profit/(Loss) for the period after tax & Exceptional items: ₹2,504.76 lakhs (Profit)
  • Total Comprehensive Income: ₹2,677.02 lakhs
  • Paid-up Equity Share Capital: ₹8,683.66 lakhs
  • Reserves excluding revaluation reserves: ₹1,38,402.35 lakhs
  • Basic EPS: ₹4.95
  • Diluted EPS: ₹4.84

Key Quantitative Figures - Consolidated (Q4 FY2026)

  • Net Profit/(Loss) for the period after tax & Exceptional items: ₹511.21 lakhs (Profit)
  • Total Comprehensive Income: ₹1,023.76 lakhs

Dates of Action

  • Board Meeting: May 28, 2026 (5:00 PM to 6:00 PM)
  • Financial Period: Quarter and Year ended March 31, 2026
  • Auditor's Report Date: May 28, 2026

Parties Involved

  • Statutory Auditors: M/s. Rattan Kaur & Associates, Chartered Accountants
  • Cost Auditors: M/s. V. Kumar & Associates, Cost Accountants (Firm Registration No. 100137)
  • Board of Directors: Approved the results
  • Audit Committee: Reviewed the results

Capital Structure Impact

  • The Company issued 1,80,93,000 equity shares during the year comprising:
  • 1,79,68,000 shares on account of conversion of share warrants
  • 1,25,000 shares under Employee Stock Option Plan 2014
  • Face value: ₹10/- each fully called up and paid up
  • During Q4 FY2026, 51,00,000 warrants were converted into equity shares
  • Total 1,95,00,000 warrants converted out of 2,60,00,000 warrants allotted
  • 65,00,000 warrants lapsed due to non-exercise of conversion right

Asset Sale Transaction

  • Company entered into agreement to sell Land and Building of Unit-IV, Baddi to Ms. Kuldeep Kaur on January 30, 2024
  • Amount received as of March 31, 2026: ₹1,710 lakhs
  • Balance payment pending: ₹110 lakhs
  • Transfer will be effected upon receipt of balance payment

Exceptional Items

  • Q4 FY2026: ₹515.24 lakhs (balances written back/written off net)
  • FY2026: ₹1,100.64 lakhs (balances written back/written off net)

Subsidiaries and Joint Ventures Included in Consolidated Results

Subsidiaries:

  • Fortune (India) Constructions Ltd.
  • MJM Remedies Private Limited
  • Ind Swift Laboratories Inc. USA
  • ISLL Middle East LLC-FZ
  • Ind-Swift India Ltd (Kenya)

Joint Ventures:

  • Indis Healthcare LLP
  • Capital Strikers LLP

Other Material Information

  • The financial results reflect the amalgamation of Ind Swift Limited (ISL) with the Company effective from August 8, 2025
  • Company issued 81,24,698 equity shares to eligible shareholders of ISL on August 25, 2025
  • Company invested available surplus funds in various investment avenues monitored by Investment Committee
  • Company holds 800 Non-Convertible Debentures of M/s. Ashok Investors Trust Ltd (face value ₹5,00,000 each), 70 debentures redeemed till March 31, 2026
  • New Labour Codes effective from November 21, 2025 - impact on employee benefit obligations recognized and not material
  • Company is exclusively in the Pharmaceutical Business segment

Cash Flow Highlights (Standalone FY2026)

  • Net Cash from Operating Activities: ₹(16,015.37) lakhs
  • Net Cash from Investing Activities: ₹(11,001.14) lakhs
  • Net Cash from Financing Activities: ₹10,525.99 lakhs
  • Net decrease in Cash: ₹(850.48) lakhs
  • Closing Cash & Cash Equivalents: ₹4,100.18 lakhs

Balance Sheet Highlights (Standalone as of March 31, 2026)

  • Total Assets: ₹1,65,434.16 lakhs
  • Total Equity: ₹1,37,069.72 lakhs
  • Total Liabilities: ₹28,364.40 lakhs
  • Non-current Assets: ₹77,993.35 lakhs
  • Current Assets: ₹87,490.81 lakhs